BTK and mantle cell lymphoma: It is worth mentioning that significant synergistic effects were observed when ironomycin combined with doxorubicin, BH3 mimetics, and Bruton’s tyrosine kinase (BTK) inhibitors in mantle cell lymphoma (Ovejero-Merino et al., 2022).